Cargando…
Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity since December 2019, in Wuhan, China. The infection has now been transmitted to more than 210 countries worldwide and caused more than 2...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580518/ https://www.ncbi.nlm.nih.gov/pubmed/33186866 http://dx.doi.org/10.1016/j.pedn.2020.10.020 |
_version_ | 1783598808372871168 |
---|---|
author | Aleebrahim-Dehkordi, Elahe Soveyzi, Faezeh Deravi, Niloofar Rabbani, Zahra Saghazadeh, Amene Rezaei, Nima |
author_facet | Aleebrahim-Dehkordi, Elahe Soveyzi, Faezeh Deravi, Niloofar Rabbani, Zahra Saghazadeh, Amene Rezaei, Nima |
author_sort | Aleebrahim-Dehkordi, Elahe |
collection | PubMed |
description | The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity since December 2019, in Wuhan, China. The infection has now been transmitted to more than 210 countries worldwide and caused more than 200,000 deaths. Similar to other coronaviruses such as Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS-CoV-2 appears to less commonly affect pediatrics and to cause less severe disease along with fewer symptoms compared to adults. Available data suggest that the pediatric population is just as likely as adults to become infected with SARS-CoV-2. However, they may be asymptotic or have milder symptoms than adults; they can be potential carriers of the disease. This article reviews the present understanding of SARS-CoV-2 infection in the pediatric age group in comparison with MERS-CoV and SARS-CoV. |
format | Online Article Text |
id | pubmed-7580518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75805182020-10-23 Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children Aleebrahim-Dehkordi, Elahe Soveyzi, Faezeh Deravi, Niloofar Rabbani, Zahra Saghazadeh, Amene Rezaei, Nima J Pediatr Nurs Article The novel coronavirus, known as 2019-nCoV or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused an epidemic with high mortality and morbidity since December 2019, in Wuhan, China. The infection has now been transmitted to more than 210 countries worldwide and caused more than 200,000 deaths. Similar to other coronaviruses such as Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS-CoV-2 appears to less commonly affect pediatrics and to cause less severe disease along with fewer symptoms compared to adults. Available data suggest that the pediatric population is just as likely as adults to become infected with SARS-CoV-2. However, they may be asymptotic or have milder symptoms than adults; they can be potential carriers of the disease. This article reviews the present understanding of SARS-CoV-2 infection in the pediatric age group in comparison with MERS-CoV and SARS-CoV. Elsevier Inc. 2021 2020-10-22 /pmc/articles/PMC7580518/ /pubmed/33186866 http://dx.doi.org/10.1016/j.pedn.2020.10.020 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Aleebrahim-Dehkordi, Elahe Soveyzi, Faezeh Deravi, Niloofar Rabbani, Zahra Saghazadeh, Amene Rezaei, Nima Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children |
title | Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children |
title_full | Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children |
title_fullStr | Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children |
title_full_unstemmed | Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children |
title_short | Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children |
title_sort | human coronaviruses sars-cov, mers-cov, and sars-cov-2 in children |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580518/ https://www.ncbi.nlm.nih.gov/pubmed/33186866 http://dx.doi.org/10.1016/j.pedn.2020.10.020 |
work_keys_str_mv | AT aleebrahimdehkordielahe humancoronavirusessarscovmerscovandsarscov2inchildren AT soveyzifaezeh humancoronavirusessarscovmerscovandsarscov2inchildren AT deraviniloofar humancoronavirusessarscovmerscovandsarscov2inchildren AT rabbanizahra humancoronavirusessarscovmerscovandsarscov2inchildren AT saghazadehamene humancoronavirusessarscovmerscovandsarscov2inchildren AT rezaeinima humancoronavirusessarscovmerscovandsarscov2inchildren |